Present Knowledge in Food Safety is a comprehensive resource that addresses food safety concerns and scientific advancements along the farm-to-consumption supply chain.
ILSI SEA Region initiates and coordinates scientific programs, research, as well as knowledge and information dissemination in Southeast Asia, Australia, New Zealand and the Pacific Islands. Read more
ILSI Southeast Asia Region and the Department of Metabolism, Nutrition and Health, Lee Kong Chian School of Medicine, Nanyang Technological University (NTU), Singapore are hosting a guest lecture by Prof. Dr. Sunil Wimalawansa to share the latest insights on vitamin D and CVD, and its implications in Asia.
ILSI Southeast Asia Region, Institute for Human Development and Potential (IHDP), A*STAR, Singapore, and Human Potential Translational Research Programme (HPTRP), Yong Loo Lin School of Medicine, National University of Singapore, are organizing a symposium to share key insights on improving nutrient clinical trial design for disease prevention, focusing on vitamin D and related health outcomes.
The role of vitamin D in reducing cardiovascular disease (CVD) risk remains debated despite growing evidence, with observational studies consistently linking low serum vitamin D levels with higher CVD risk. Its role in modulating inflammation and oxidative stress, improving endothelial function, and reducing cardiometabolic risk factors supports a comprehensive, multi-modal approach to cardiovascular health. In Singapore, 30-50% of the population, with prevalence higher in Malay ethnic groups, indoor workers etc., remains vitamin D deficient or insufficient despite year-round sunshine.
ILSI Southeast Asia Region and the Department of Metabolism, Nutrition and Health, Lee Kong Chian School of Medicine, Nanyang Technological University (NTU), Singapore are hosting a guest lecture by Prof. Dr. Sunil Wimalawansa to share the latest insights on vitamin D and CVD, and its implications in Asia.
ABOUT THE SPEAKER
Prof Dr Sunil J. Wimalawansa
Professor of Medicine, Endocrinology & Nutrition; Director, Cardio-Metabolic & Endocrine Institute, New Jersey, USA
Prof Dr Sunil Wimalawansa is a globally renowned expert in endocrinology, osteoporosis and metabolic bone diseases, as well as nutrition and vitamin D. A clinician-scientist with more than three decades of experience, he has served on the scientific review committee of the US NIH and was a past board member of the American Association for Endocrinology.
Prof Dr Sunil J. Wimalawansa, Professor of Medicine, Endocrinology & Nutrition; Director, Cardio-Metabolic & Endocrine Institute, New Jersey, USA
Prof. Dr. Wimalawansa is a Professor of Medicine, Director of the CardioMetabolic & Endocrine Institute, and formerly University Professor and Chief of Endocrinology, Metabolism & Nutrition, UMDNJ/Rutgers University. His PhD from the University of London(UK) is in endocrine pathology. Dr. Wimalawansa is globally renowned in endocrinology, with broad expertise in internal medicine, endocrinology, osteoporosis and metabolic bone diseases, chronic kidney disease, nutrition, vitamin D, water and sanitation, and environmental issues. He is a clinician-scientist with more than three decades of experience, a faculty member, medical educator, author, researcher, innovator, administrator, leader, and philanthropist.
He has served on several national and international scientific review committees, including the US NIH, the US Veterans Administration, the Drug Enforcement Agency, and NASA. He is a past board member of the American Association for Endocrinology (AACE/national organization) (2011-2015) and the International Society for Clinical Densitometry (ISCD).
Dr. Wimalawansa has published over 300 peer-reviewed research articles (11,100+ citations; h-Index of 40), 45 reviews and proceedings, 15 book chapters, and 5 medical books. He holds five medical patents in cardiovascular, osteoporosis, and preeclampsia of pregnancy. He is the author of the book, "Vitamin D: Everything You Need to Know" (2012).
He has made several seminal contributions to medicine, medical research, public health, and pharmaceuticals. These include development of novel modes of treating osteoporosis, including combination therapies (1985), nitroglycerine (1987), once-a-week bisphosphonates therapy (1995), and a technique to enhance the efficacy of bisphosphonates (1997); and cost-effective therapies, such as nitric oxide donor treatment (e.g., topical nitroglycerine and oral nitrates; 1987) and vitamin E regimens for treating osteoporosis (1997).
REGISTRATION
This symposium offers complimentary registration. Due to limited seating, early registration is highly encouraged. Register now by clicking the button below:
Obesity, osteoporosis and sarcopenia present enormous global health and economic challenges, which are exacerbated in aging populations. Singapore is one of the countries with the highest prevalence of osteoporotic hip fractures in the world. A recent study in Singapore has studied complex relationships between fat mass (FM), lean mass (LM), and bone mass, with significant implications for obesity, frailty, and bone fractures later in life.
Vitamin D is essential for bone health, but also for many roles beyond the musculoskeletal system, including the immune, pulmonary, and cardiovascular systems; pregnancy; autoimmune disorders; and cancer. However, inappropriate or flawed study designs have been frequently found in clinical trials, which led to misleading interpretations.
Evidence from adequately powered epidemiological studies and RCTs in vitamin D-deficient populations shows favorable clinical outcomes, enriching the literature and improves understanding of its physiology and mechanisms. Proper study designs with rigorous methodologies and cautious interpretation of outcomes are crucial, and these principles are equally relevant to other micronutrients and nutrient/nutraceutical research, enhancing the credibility of clinical trials, systematic reviews, and meta-analyses.
ILSI Southeast Asia Region, Institute for Human Development and Potential (IHDP), A*STAR, Singapore, and Human Potential Translational Research Programme (HPTRP), Yong Loo Lin School of Medicine, National University of Singapore are organizing a symposium to share key insights on improving nutrient clinical trial design for disease prevention, focusing on vitamin D and related health outcomes.
SPEAKERS
REGISTRATION
This symposium offers complimentary registration. Due to limited seating, early registration is highly encouraged. Register now by clicking the button below:
The role of vitamin D in reducing cardiovascular disease (CVD) risk remains debated despite growing evidence, with observational studies consistently linking low serum vitamin D levels with higher CVD risk. Its role in modulating inflammation and oxidative stress, improving endothelial function, and reducing cardiometabolic risk factors supports a comprehensive, multi-modal approach to cardiovascular health. In Singapore, 30-50% of the population, with prevalence higher in Malay ethnic groups, indoor workers etc., remains vitamin D deficient or insufficient despite year-round sunshine.
ILSI Southeast Asia Region and the Department of Metabolism, Nutrition and Health, Lee Kong Chian School of Medicine, Nanyang Technological University (NTU), Singapore are hosting a guest lecture by Prof. Dr. Sunil Wimalawansa to share the latest insights on vitamin D and CVD, and its implications in Asia.
ABOUT THE SPEAKER
Prof Dr Sunil J. Wimalawansa
Professor of Medicine, Endocrinology & Nutrition; Director, Cardio-Metabolic & Endocrine Institute, New Jersey, USA
Prof Dr Sunil Wimalawansa is a globally renowned expert in endocrinology, osteoporosis and metabolic bone diseases, as well as nutrition and vitamin D. A clinician-scientist with more than three decades of experience, he has served on the scientific review committee of the US NIH and was a past board member of the American Association for Endocrinology.
Prof Dr Sunil J. Wimalawansa, Professor of Medicine, Endocrinology & Nutrition; Director, Cardio-Metabolic & Endocrine Institute, New Jersey, USA
Prof. Dr. Wimalawansa is a Professor of Medicine, Director of the CardioMetabolic & Endocrine Institute, and formerly University Professor and Chief of Endocrinology, Metabolism & Nutrition, UMDNJ/Rutgers University. His PhD from the University of London(UK) is in endocrine pathology. Dr. Wimalawansa is globally renowned in endocrinology, with broad expertise in internal medicine, endocrinology, osteoporosis and metabolic bone diseases, chronic kidney disease, nutrition, vitamin D, water and sanitation, and environmental issues. He is a clinician-scientist with more than three decades of experience, a faculty member, medical educator, author, researcher, innovator, administrator, leader, and philanthropist.
He has served on several national and international scientific review committees, including the US NIH, the US Veterans Administration, the Drug Enforcement Agency, and NASA. He is a past board member of the American Association for Endocrinology (AACE/national organization) (2011-2015) and the International Society for Clinical Densitometry (ISCD).
Dr. Wimalawansa has published over 300 peer-reviewed research articles (11,100+ citations; h-Index of 40), 45 reviews and proceedings, 15 book chapters, and 5 medical books. He holds five medical patents in cardiovascular, osteoporosis, and preeclampsia of pregnancy. He is the author of the book, "Vitamin D: Everything You Need to Know" (2012).
He has made several seminal contributions to medicine, medical research, public health, and pharmaceuticals. These include development of novel modes of treating osteoporosis, including combination therapies (1985), nitroglycerine (1987), once-a-week bisphosphonates therapy (1995), and a technique to enhance the efficacy of bisphosphonates (1997); and cost-effective therapies, such as nitric oxide donor treatment (e.g., topical nitroglycerine and oral nitrates; 1987) and vitamin E regimens for treating osteoporosis (1997).
REGISTRATION
This symposium offers complimentary registration. Due to limited seating, early registration is highly encouraged. Register now by clicking the button below:
Join our NewsFlash and Nano Alert mailing list to receive the latest scientific updates in nutrition, food innovations, safety issues and nanotechnology applications in food, agriculture, food packaging, skin care, medical applications with potential links to those focus topics, and related toxicology and risk assessment.
This site uses cookies to provide you with a personalized browsing experience. By clicking “I Agree” or continuing to use the site you agree to allow cookies to be placed and accept the terms set out in our [Privacy Notice]. Please read the Privacy Notice for more information on how we handle information collected from users and how you can control the use of such information.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Prof Dr Sunil J. Wimalawansa, Professor of Medicine, Endocrinology & Nutrition; Director, Cardio-Metabolic & Endocrine Institute, New Jersey, USA 
